Wöchentliche Marktübersicht | Eine erhöhte Dosis von Semaglutid zeigt bemerkenswerte Effekte bei der Gewichtsabnahme; Die Emissionspreis von Saint Bella bei der IPO in Hongkong liegt bei 6,58 Hongkongdollar pro Aktie; Etwa 190 Unternehmen stehen in der Warteschlange für die Börsengänge an der Hongkonger Börse.
Weekly Market Review
A-shares
This week (from June 16th to 20th), the A-share market index fluctuated downward. The Shanghai Composite Index slightly declined by 0.51% during the week, closing at 3,360 points on June 20th. The Wind All-China Index dropped by 1.07% this week. In terms of sectors, among the 31 first-tier industries of Shenwan, only the banking, communication, and electronics sectors rose this week. The beauty care, textile and apparel, pharmaceutical biology, non-ferrous metals, and social services sectors led the decline this week.
Hong Kong Stocks
The trend of the Hong Kong stock market was similar to that of the A-share market. The Hang Seng Index fell by 1.52% during the week, and the Hang Seng Tech Index dropped by 2.03% this week. In terms of sectors, among the 12 Hang Seng industry indices, only the information technology sector rose this week. The healthcare, energy, and raw materials sectors had relatively large declines this week.
U.S. Stocks
The three major U.S. stock indices showed a divergent performance this week. The Dow Jones and Nasdaq rose, while the S&P 500 fell.
Positive News of the Week
At the American Diabetes Association (ADA) Scientific Sessions held in Chicago, the United States, Novo Nordisk announced the results of the STEP UP Phase 3b clinical trial for obese patients without diabetes. The STEP UP trial showed that at week 72, subjects who received a higher dose of Wegovy (7.2 mg of weight-loss semaglutide) achieved an average weight loss of 21% compared to the placebo group, and one-third of the subjects lost 25% or more of their body weight. Sean Wharton, the medical director of the Wharton Medical Clinic in Canada and the lead author of the study, said that the STEP UP trial shows that the dose of semaglutide can be increased to achieve more significant weight loss than before, and it is consistent with the known safety profile of semaglutide. This provides a new treatment option for patients who have not achieved their weight management goals. (The Paper)
Laofu Gold's First Store in Singapore Opens
36Kr learned that on June 21st, Laofu Gold's store in Singapore officially opened. This store is Laofu Gold's first overseas store and is generally considered a crucial step in Laofu Gold's global expansion. It is understood that the new store is located in Marina Bay Sands, a landmark high-end commercial complex in Singapore, adjacent to international luxury brands such as Louis Vuitton and Hermès.
36Kr learned that Zhejiang Hisun Pharmaceutical Co., Ltd. announced that the adsorbed tetanus vaccine developed by its wholly-owned subsidiary, Beijing Zhifei Lvzhu Biological Pharmaceutical Co., Ltd., has received the Approval Notice for Drug Clinical Trials from the National Medical Products Administration (Notice No.: 2025LP01605), allowing the product to conduct clinical trials for the prevention of tetanus. The company will carry out relevant clinical trial work as soon as possible in accordance with the requirements of the approval notice.
Tencent Releases AI Builder, Supporting One-Sentence Generation of Complete Applications
36Kr learned that on June 16th, Tencent CloudBase released "AI Builder." Users can simply describe their requirements in one sentence, and the AI can generate a complete webpage, mini-program, or application, and support partial modifications. You can say where to modify and it will be modified accordingly. At the same time, to meet the needs of professional developers, CloudBase AI Builder can generate the front-end and back-end of a complete project and support exporting the code package for in-depth modification and customization. In addition, based on the Serverless capabilities such as cloud database, cloud hosting, and cloud functions provided by the CloudBase platform, CloudBase AI Builder can achieve one-click deployment and release of applications. This greatly enhances the experience of creating, modifying, and launching applications.
Xinxuan Group's 618: 12 Brands Exceeded 100 Million in Sales, with a Total Audience of 550 Million
36Kr learned that according to the person in charge of Xinxuan's operations, as of June 18th, Xinxuan's 618 promotion arranged nearly 200 live broadcasts, including 10 broadcasts with sales exceeding 100 million. The total number of goods sold exceeded 33 million orders, and the total audience in the live broadcast rooms reached 550 million. According to statistics, more than 2,200 brands participated in Xinxuan's 618 promotion, with nearly 20,000 core SKUs, covering popular products in all categories and major brands. Among them, 12 brands such as Chow Tai Seng, Whoo, Haier, Oppein, and vivo exceeded 100 million in sales in Xinxuan's live broadcast rooms, and 79 brands exceeded 10 million in sales.
Jiangsu Hengrui Medicine Co., Ltd.: Receives Approval Notices for Clinical Trials of Six Drugs
36Kr learned that Jiangsu Hengrui Medicine Co., Ltd. announced that the company and its subsidiaries have received the "Approval Notices for Drug Clinical Trials" from the National Medical Products Administration for six drugs, including SHR2554 tablets and SHR-A1811 for injection, and will conduct clinical trials in the near future. These drugs include the new oral EZH2 inhibitor SHR2554 tablets, the HER2-targeted antibody-drug conjugate SHR-A1811 for injection, the Nectin-4-targeted antibody-drug conjugate SHR-A2102 for injection, the humanized anti-PD-L1 monoclonal antibody Adalimumab injection, the Claudin18.2-targeted antibody-drug conjugate SHR-A1904 for injection, and the anti-PD-L1/TGF-βRII bifunctional fusion protein SHR-1701 injection.
Li Auto's First Pure-Electric SUV to Be Launched in Late July
36Kr learned that Li Xiang, the CEO of Li Auto, revealed in a Weibo post that the Li Auto i8 will be launched in late July. Currently, the internal preparations for the production, training, and delivery of the Li Auto i8 are in the final stage. It is understood that the i8 is Li Auto's first pure-electric SUV and the first product in the i series, targeting the mid-large six-seater SUV market.
Yingmu Technology: Will Release a New Strategic Product in the Third Quarter
36Kr learned that Yingmu Technology will release a new strategic product in the third quarter of this year. It is also known that after the 618 promotion officially ended, Yingmu Technology ranked first in both the single-product list and the brand list of the XR and AI glasses categories on the JD platform.
36Kr learned that Desay SV said on the interactive platform that in 2024, the company's R & D investment reached 2.192 billion yuan, accounting for 7.94% of its sales. The company has reached a cooperation agreement with Chery Automobile to jointly develop a cockpit-driving integrated central computing platform. This platform is based on the company's independently developed intelligent central computing platform ICPS01E and uses an innovative single-chip multi-domain fusion solution, becoming the industry's first mass-producible cockpit-driving integrated SOC product, marking a major breakthrough for the company in the field of intelligent driving core technology. At the same time, the company has signed a strategic cooperation agreement with Hyper and will jointly research and develop to promote the accelerated implementation of the next-generation cockpit-driving integrated and even central computing platform based on the new-generation high-computing chips to meet the requirements of L4 high-level autonomous driving software and hardware systems.
Negative News of the Week
Anker Innovations announced on June 20th that due to the discovery of incoming material quality issues with a certain type of industry-standard battery cells, it will actively recall some batches of basic mobile power banks with the models A1642/A1647/A1652/A1680/A1681/A1689/A1257. According to the announcement, Anker immediately submitted a recall application to the regulatory authorities after discovering the problem, terminated the cooperation with the involved supplier, and all relevant risky products have been taken off the shelves. At the same time, it reminded relevant users to check whether their power banks are on the recall list, stop using the risky power banks in time, and actively participate in the recall program. In addition to initiating the recall, Anker Innovations will also establish a long-term guarantee mechanism to ensure the safety of mobile power bank products through full-link control.
36Kr learned that from June 16th to June 20th, 2025, the Shanghai Stock Exchange took regulatory measures such as written warnings for 108 cases of abnormal securities trading behaviors such as price manipulation and false declarations, conducted focused monitoring on abnormally fluctuating risk-warning stocks such as *ST Yazhen and stocks in the delisting consolidation period, and carried out special investigations on 21 major matters of listed companies.
36Kr learned that Ningbo Huaxiang announced that it expects to report a net loss attributable to shareholders of the listed company of 273 million to 369 million yuan in the first half of 2025, compared with a profit of 534 million yuan in the same period last year. The net profit after deducting non-recurring gains and losses is expected to be 495 million to 591 million yuan, an increase of 5.25% to 25.73% compared with the same period last year. The basic earnings per share are expected to be a loss of 0.34 to 0.45 yuan per share. The main reason for the performance change is that the divestiture of European business had a one-time impact of approximately 898 million yuan on the company, which is a non-recurring gain or loss item.
*ST Jingang: Receives a Decision to Terminate Stock Listing
36Kr learned that *ST Jingang announced that on June 20th, 2025, the company received a self-regulatory supervision decision from the Shanghai Stock Exchange, deciding to terminate the listing of the company's stocks. The types of securities whose listing will be terminated include RMB ordinary shares (A-shares) and domestic-listed foreign shares (B-shares), with the stock abbreviations *ST Jingang and *ST Jingang B. The starting date for the company's stocks to enter the delisting consolidation period is June 30th, 2025, and the expected last trading date is July 18th, 2025. The trading period of the delisting consolidation period is 15 trading days. The Shanghai Stock Exchange will delist the company's stocks within 5 trading days after the expiration of the delisting consolidation period, and the listing of the stocks will be terminated. The company will transfer to the National Equities Exchange and Quotations for share transfer.
SpaceX's Starship Explodes and Disintegrates During Pre-Flight Test
SpaceX's Starship S36 spacecraft exploded during a test on June 18th. Just as the engines were ignited, the spacecraft suddenly exploded and disintegrated, and a huge fireball shot into the sky. SpaceX is investigating the cause of the explosion. This was a static fire test before the Starship's test flight, and the spacecraft was originally scheduled to conduct its tenth test flight on June 30th. On May 27th, the Starship conducted its ninth test flight, and the second-stage spacecraft of the rocket lost control and disintegrated after entering space. (Caixin)
Microsoft Plans to Lay Off Thousands of Employees
It is reported that Microsoft plans to lay off thousands of employees, mainly targeting sales personnel. (Caixin)
*ST Xinyuan: The Company's Actual Controller and Chairman Are Restricted from High-Consumption
36Kr learned that *ST Xinyuan issued an announcement stating that the company recently learned that Wu Xianlong, the actual controller and chairman of the company, has been restricted from high-consumption. The case involves a contract dispute between the company and Fuzhou Linchuan District State-owned Assets Investment and Holding Group Co., Ltd. The restriction on Wu Xianlong's high-consumption will not have a direct impact on the company's daily operations and financial situation. The company is currently operating normally, and Wu Xianlong and the company are actively resolving this issue.
*ST Hengli: Receives a Decision to Terminate Stock Listing
36Kr learned that *ST Hengli issued an announcement stating that on June 17th, the company received a decision from the Shenzhen Stock Exchange to terminate the listing of the company's stocks. The company's stocks resumed trading on June 25th and entered the delisting consolidation period. The trading period of the delisting consolidation period is 15 trading days, and the expected last trading date is July 15th.
Honda Recalls Nearly 260,000 Cars in the United States Due to Brake Pedal Issues
The U.S. National